American Society of Clinical Oncology

SHERPA: White

People

  1. Chen
    Chen
  2. Scher
    Scher
  3. Morris
    Morris
  4. Sawyers
    Sawyers
  5. Rathkopf
    Rathkopf
  6. Slovin
    Slovin
  7. Autio
    Autio
  8. Carver
    Carver
  9. Danila
    Danila
  10. Schultz
    Schultz

Groups

  1. Department of Medicine (13)
  2. GSK Faculty (13)
  3. Genitourinary Oncology Service (13)
  4. Human Oncology and Pathogenesis Program (13)
  5. Solid Tumor Oncology Division (13)
  6. Hematologic Malignancies, Division of (10)
  7. Tow Center for Developmental Oncology (TCDO) (7)
  8. Center for Hematologic Malignancies (6)
  9. Executive Committee, Center for Hematologic Malignancies (6)
  10. Sloan Kettering Institute Postdocs (5)
Search Within
  1. "Human Oncology and Pathogenesis Program"
  2. "Yu Chen"
Formats
  1. Meeting Abstract (11)
  2. Journal Article (2)
Groups
  1. Department of Medicine (13)
  2. GSK Faculty (13)
  3. Genitourinary Oncology Service (13)
  4. Human Oncology and Pathogenesis Program (13)
  5. Solid Tumor Oncology Division (13)
  6. Hematologic Malignancies, Division of (10)

More Groups

People
  1. Yu Chen (13)
  2. Howard Scher (9)
  3. Michael Morris (7)
  4. Charles Sawyers (6)
  5. Dana Rathkopf (5)
  6. Susan Slovin (5)

More People

Years
  1. 2023 (1)
  2. 2022 (1)
  3. 2020 (1)
  4. 2017 (2)
  5. 2016 (1)
  6. 2014 (3)

More Years

Publications
  1. Journal of Clinical Oncology (12)
  2. JCO Precision Oncology (1)

Results (13)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Effect of Janus kinase (JAK) signaling inhibition on lineage plasticity and drug sensitivity in castrate resistant prostate cancer
    Meeting Abstract

    Zaidi, S.; Chan, J. M.; Love, J.; Zhao, J.; Setty, M.; Lawrence, K.; Gopalan, A.; Goodrich, D.; Morris, M. J.; Chen, Y.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Phase II trial of imatinib plus binimetinib in patients with treatment-naive advanced gastrointestinal stromal tumor
    Journal Article

    Chi, P.; Qin, L. X.; Nguyen, B.; Kelly, C. M.; D'Angelo, S. P.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; Movva, S.; Nacev, B. A.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Dickkopf-1 can lead to immune evasion in metastatic castration-resistant prostate cancer
    Journal Article

    Wise, D. R.; Schneider, J. A.; Armenia, J.; Febles, V. A.; McLaughlin, B.; Brennan, R.; Thoren, K. L.; Abida, W.; Sfanos, K. S.; De Marzo, A. M.; more...
    JCO Precision Oncology (2020)

    Fulltext@MSK | Save
  • The immunomodulatory protein Dickkopf-1 (DKK1) defines a non-neuroendocrine subtype of metastatic castration-resistant prostate cancer (mCRPC) with low AR and low PSA expression
    Meeting Abstract

    Wise, D.; Armenia, J.; Chen, Y.; Nelson, P.; Schultz, N.; Sawyers, C. L.; Scher, H. I.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Circulating tumor cells (CTCs) N-terminal androgen receptor expression to identify patients (pts) with castrate resistant prostate cancer (CRPC) who are more sensitive to chemotherapy
    Meeting Abstract

    Slovin, S. F.; Knudsen, K. E.; Halabi, S.; Carbone, E.; Fernandez, C.; Chen, Y.; Autio, K. A.; Rathkopf, D. E.; Kampel, L.; Morris, M. J.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Exploring the role of RB and AR in a phase II randomized multicenter trial of abiraterone acetate with or without cabazitaxel in metastatic castration resistant prostate cancer (mCRPC)
    Meeting Abstract

    Slovin, S. F.; Knudsen, K. E.; Carbone, E.; Showunmi, A.; Hullings, M.; Morris, M. J.; Autio, K. A.; Kampel, L. J.; Molina, A. M.; Chen, Y.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Establishing a neoadjuvant platform for developing targeted agents: Degarelix prior to prostatectomy for patients with intermediate- and high-risk prostate cancer
    Meeting Abstract

    Touijer, K. A.; Carver, B. S.; Coleman, J. A.; Laudone, V. P.; Hullings, M.; Ehrlich, S. S.; DeNunzio, M.; Reuter, V. E.; Eastham, J. A.; Danila, D. C.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Targeting reciprocal feedback inhibition in the clinic: ARN509 and PI3K pathway inhibition in patients with metastatic castration-resistant prostate cancer (mCRPC)
    Meeting Abstract

    Rathkopf, D. E.; Carver, B. S.; Chen, Y.; Morris, M. J.; Danila, D. C.; Slovin, S. F.; Autio, K. A.; DeNunzio, M.; Sawyers, C. L.; Scher, H. I.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Development of novel metastatic prostate cancer cell lines by "organoid" in vitro culture technology
    Meeting Abstract

    Vela, I.; Gao, D.; Gopalan, A.; Sboner, A.; Undvall, E.; Wanjala, J.; Iaquinta, P.; Wongvipat, J.; Karthaus, W.; Clevers, H.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Effect of margin width on local recurrence (LR) in triple-negative (TN) breast cancer treated with breast-conserving therapy (BCT)
    Meeting Abstract

    Pilewskie, M. L.; Ho, A. Y.; Orell, E.; Stempel, M.; Chen, Y.; Eaton, A.; Patil, S.; Morrow, M.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save